Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model
Objective. To study pharmacodynamics of meropenem alone and in combination with avibactam in an in vitro dynamic model; to evaluate effectiveness of meropenem against K. pneumoniae strains producing and not producing carbapenemases; to study impact of bacterial inoculum on meropenem activity and it...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2025-03-01
|
| Series: | Клиническая микробиология и антимикробная химиотерапия |
| Subjects: | |
| Online Access: | https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p33/cmac-2025-t27-n1-p33.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849423797421080576 |
|---|---|
| author | Strukova E.N. golikova-mv. |
| author_facet | Strukova E.N. golikova-mv. |
| author_sort | Strukova E.N. |
| collection | DOAJ |
| description | Objective.
To study pharmacodynamics of meropenem alone and in combination with avibactam in an in vitro dynamic model; to evaluate effectiveness of meropenem against K. pneumoniae strains producing and not producing carbapenemases; to study impact of bacterial inoculum on meropenem activity and its effects.
Materials and Methods.
K. pneumoniae producing KPC and OXA-48 carbapenemases and non-producing strains were exposed to meropenem or its combination with avibactam (carbapenemase-producing strains only) in a modified in vitro hollow-fiber infection model (pneumoniae) simulating human pharmacokinetics of drugs administrated thrice daily for 5 days. The antimicrobial effect against the total population of K. pneumoniae was evaluated at different starting bacterial inocula (106 and 108 CFU/ml) by plating the samples on the agar media.
Results.
In the hollow-fiber infection model, the effect of meropenem was bactericidal for carbapenemase non-producing K. pneumoniae with MICs 2–4 mg/L, while carbapenemase-producing strains with comparable MICs of meropenem predominantly demonstrated rapid regrowth at both high and low starting inocula. The addition of avibactam led to an increased effect of meropenem and a decrease in the number of bacterial cells of all three carbapenemase-producing K. pneumoniae at both starting inocula.
Conclusions.
Based on meropenem susceptibility data of K. pneumoniae without checking the ability to carbapenemase production it is impossible to guarantee a successful outcome of carbapenem therapy with both low (imitation of mild infection) and high (imitation of severe infection) inocula. Addition of avibactam significantly enhanced the effect of meropenem on all carbapenemase-producing strains. |
| format | Article |
| id | doaj-art-e516db00b2eb4705b0a49abadc2b0e20 |
| institution | Kabale University |
| issn | 1684-4386 2686-9586 |
| language | Russian |
| publishDate | 2025-03-01 |
| publisher | Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy |
| record_format | Article |
| series | Клиническая микробиология и антимикробная химиотерапия |
| spelling | doaj-art-e516db00b2eb4705b0a49abadc2b0e202025-08-20T03:30:28ZrusInterregional Association for Clinical Microbiology and Antimicrobial ChemotherapyКлиническая микробиология и антимикробная химиотерапия1684-43862686-95862025-03-01271334110.36488/cmac.2025.1.33-41cmac-2025-t27-n1-p33Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic modelStrukova E.N.0golikova-mv.1Gause Institute of New Antibiotics, Moscow, RussiaGause Institute of New Antibiotics, Moscow, RussiaObjective. To study pharmacodynamics of meropenem alone and in combination with avibactam in an in vitro dynamic model; to evaluate effectiveness of meropenem against K. pneumoniae strains producing and not producing carbapenemases; to study impact of bacterial inoculum on meropenem activity and its effects. Materials and Methods. K. pneumoniae producing KPC and OXA-48 carbapenemases and non-producing strains were exposed to meropenem or its combination with avibactam (carbapenemase-producing strains only) in a modified in vitro hollow-fiber infection model (pneumoniae) simulating human pharmacokinetics of drugs administrated thrice daily for 5 days. The antimicrobial effect against the total population of K. pneumoniae was evaluated at different starting bacterial inocula (106 and 108 CFU/ml) by plating the samples on the agar media. Results. In the hollow-fiber infection model, the effect of meropenem was bactericidal for carbapenemase non-producing K. pneumoniae with MICs 2–4 mg/L, while carbapenemase-producing strains with comparable MICs of meropenem predominantly demonstrated rapid regrowth at both high and low starting inocula. The addition of avibactam led to an increased effect of meropenem and a decrease in the number of bacterial cells of all three carbapenemase-producing K. pneumoniae at both starting inocula. Conclusions. Based on meropenem susceptibility data of K. pneumoniae without checking the ability to carbapenemase production it is impossible to guarantee a successful outcome of carbapenem therapy with both low (imitation of mild infection) and high (imitation of severe infection) inocula. Addition of avibactam significantly enhanced the effect of meropenem on all carbapenemase-producing strains.https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p33/cmac-2025-t27-n1-p33.pdfmeropenemavibactamklebsiella pneumoniaecarbapenemasesin vitro dynamic model |
| spellingShingle | Strukova E.N. golikova-mv. Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model Клиническая микробиология и антимикробная химиотерапия meropenem avibactam klebsiella pneumoniae carbapenemases in vitro dynamic model |
| title | Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model |
| title_full | Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model |
| title_fullStr | Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model |
| title_full_unstemmed | Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model |
| title_short | Pharmacodynamics of meropenem and meropenem combined with avibactam against Klebsiella pneumoniae in an in vitro dynamic model |
| title_sort | pharmacodynamics of meropenem and meropenem combined with avibactam against klebsiella pneumoniae in an in vitro dynamic model |
| topic | meropenem avibactam klebsiella pneumoniae carbapenemases in vitro dynamic model |
| url | https://cmac-journal.ru/publication/2025/1/cmac-2025-t27-n1-p33/cmac-2025-t27-n1-p33.pdf |
| work_keys_str_mv | AT strukovaen pharmacodynamicsofmeropenemandmeropenemcombinedwithavibactamagainstklebsiellapneumoniaeinaninvitrodynamicmodel AT golikovamv pharmacodynamicsofmeropenemandmeropenemcombinedwithavibactamagainstklebsiellapneumoniaeinaninvitrodynamicmodel |